Document Detail


Myocardial ischemia-reperfusion injury: a neglected therapeutic target.
MedLine Citation:
PMID:  23281415     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute myocardial infarction (MI) is a major cause of death and disability worldwide. In patients with MI, the treatment of choice for reducing acute myocardial ischemic injury and limiting MI size is timely and effective myocardial reperfusion using either thombolytic therapy or primary percutaneous coronary intervention (PPCI). However, the process of reperfusion can itself induce cardiomyocyte death, known as myocardial reperfusion injury, for which there is still no effective therapy. A number of new therapeutic strategies currently under investigation for preventing myocardial reperfusion injury have the potential to improve clinical outcomes in patients with acute MI treated with PPCI.
Authors:
Derek J Hausenloy; Derek M Yellon
Related Documents :
24069305 - Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated volt...
12446055 - Positron emission tomography and recovery following revascularization (parr-1): the imp...
23963125 - Preliminary report on cardiac dysfunction after isolated traumatic brain injury.
22493615 - Subarachnoid hemorrhage mimicking leakage of contrast media after coronary angiography.
11850335 - Protective effects of cyclosporin a from endotoxin-induced myocardial dysfunction and a...
18006165 - Takotsubo cardiomyopathy in a 52 year old patient.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2013-01-02
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  123     ISSN:  1558-8238     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-02     Completed Date:  2013-03-11     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  92-100     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Death
Humans
Myocardial Infarction / complications,  metabolism,  pathology,  physiopathology*,  therapy*
Myocardial Reperfusion Injury / etiology,  metabolism,  pathology,  physiopathology*,  prevention & control*
Myocytes, Cardiac / metabolism,  pathology
Percutaneous Coronary Intervention*
Thrombolytic Therapy*
Grant Support
ID/Acronym/Agency:
FS/06/023//British Heart Foundation; RG/03/007//British Heart Foundation; RG/08/015/26411//British Heart Foundation; //Department of Health
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmias.
Next Document:  S-nitrosylation: integrator of cardiovascular performance and oxygen delivery.